About Endovascular Engineering
Endovascular Engineering is a company based in Menlo Park (United States) founded in 2019. Endovascular Engineering has raised $122 million across 4 funding rounds from investors including HHS, Cordis and 415 Capital. Endovascular Engineering offers products and services including Hēlo Thrombectomy System. Endovascular Engineering operates in a competitive market with competitors including Inari Medical, Akura Medical, Magneto Thrombectomy, EmerStat and Retriever Medical, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$122 M (USD)
in 4 rounds
-
Latest Funding Round
$80 M (USD), Series C
Apr 07, 2026
-
Investors
HHS
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Endovascular Engineering
Endovascular Engineering offers a comprehensive portfolio of products and services, including Hēlo Thrombectomy System.
Device for breaking down and removing blood clots via agitation and aspiration.
People of Endovascular Engineering
Unlock access to complete
Funding Insights of Endovascular Engineering
Endovascular Engineering has successfully raised a total of $122M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $80 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Endovascular Engineering
Endovascular Engineering has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Cordis and 415 Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in medical technology innovations.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital investments are provided to Texas-based startups.
|
Locked | Locked | Locked |
Investor details for Endovascular Engineering
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Endovascular Engineering
Investment portfolio details for Endovascular Engineering
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Endovascular Engineering
Detailed financials for Endovascular Engineering
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endovascular Engineering Comparisons
Peer comparison for Endovascular Engineering
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endovascular Engineering
Endovascular Engineering operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inari Medical, Akura Medical, Magneto Thrombectomy, EmerStat and Retriever Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Catheter-based thrombectomy devices for vascular emboli removal are developed.
|
|
| Locked | Locked | Locked |
Catheter-based thrombectomy devices for thrombus removal are developed.
|
|
| Locked | Locked | Locked |
Thrombectomy solutions are developed for blood clot removal in arteries.
|
|
| Locked | Locked | Locked |
Creates innovative hemostatic devices for efficient trauma care and surgical applications.
|
|
| Locked | Locked | Locked |
Provides medical devices for vascular care and clot removal treatments.
|
Detailed competitors of Endovascular Engineering
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endovascular Engineering
Complete news archive for Endovascular Engineering
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endovascular Engineering
Endovascular Engineering was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Endovascular Engineering is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Endovascular Engineering is a funded company, having raised a total of $122M across 4 funding rounds to date.
Endovascular Engineering was established in 2019 in Menlo Park, United States. Services in engineering are offered to companies involved in medical device manufacturing. Focus is placed on supporting product development and production processes within the medical technology sector. Operations are conducted from the United States, with resources accessible via the domain endovascularengineering.com. Expertise is directed toward endovascular applications in device engineering.
Endovascular Engineering's top competitors include Inari Medical, Akura Medical and Magneto Thrombectomy.
Endovascular Engineering offers Hēlo Thrombectomy System.
Endovascular Engineering has 9 investors. Key investors include HHS, Cordis, 415 Capital, Panakes Partners, and S3 Ventures.